CDKN2A and neoplasm: Although p16INK4a was thought to be the predominant tumor suppressor at 9p21, observations from melanoma-prone families in which exon 1β germline deletion or mutation in either the coding region or splice donor site of this exon have been reported supporting a p16INK4a-independent tumor suppressor role for p14ARF [69–71].